Â¥
2.31
May 10
New Key Statistics Module, Z-Score and F-Score
SZSE:000627 Key Ratios
Market Cap ¥ M | 11,412.85 |
Enterprise Value ¥ M | 12,232.71 |
P/E(ttm) | -- |
PE Ratio without NRI | 22.65 |
Forward PE Ratio | -- |
Price/Book | 0.56 |
Price/Sales | 0.26 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 1.08 |
Revenue (TTM) ¥ M | 45,258.00 |
EPS (TTM) ¥ | -0.16 |
Beneish M-Score | -1.58 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 13.20 |
y-y EBITDA Growth Rate % | -59.10 |
EV-to-EBIT | 1.02 |
EV-to-EBITDA | 1.02 |
PEG | 1.72 |
Shares Outstanding M | 4,940.63 |
Net Margin (%) | -1.74 |
Operating Margin % | 26.69 |
Pre-tax Margin (%) | -4.74 |
Quick Ratio | 1.71 |
Current Ratio | 1.90 |
ROA % (ttm) | -0.26 |
ROE % (ttm) | -3.77 |
ROIC % (ttm) | 3.26 |
Dividend Yield % | 4.76 |
Altman Z-Score | 0.28 |
SZSE:000627 Number of Guru Trades
SZSE:000627 Volume of Guru Trades
Gurus Latest Trades with SZSE:000627
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000627 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Biocause Pharmaceutical Co Ltd Insider Transactions
No Available Data